AKERO THERAPEUTICS INCAKERO THERAPEUTICS INCAKERO THERAPEUTICS INC

AKERO THERAPEUTICS INC

No trades
See on Supercharts

Price target

65.800.000.00%
The 11 analysts offering 1 year price forecasts for 1AKRO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 11 analysts giving stock ratings to 1AKRO in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


1AKRO EPS for the last quarter is −0.96 EUR despite the estimation of −1.12 EUR. In the next quarter EPS is expected to reach −0.89 EUR. Track more of AKERO THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter AKERO THERAPEUTICS INC revenue is expected to reach 0.00 EUR. Check out AKERO THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, 1AKRO price target is 65.80 EUR with a max estimate of 95.86 EUR and a min estimate of 43.09 EUR. Check if this forecast comes true in a year, meanwhile watch AKERO THERAPEUTICS INC stock price chart and keep track of the current situation with 1AKRO news and stock market news.
We've gathered opinions of 11 analysts rating 1AKRO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.